alitretinoin + betamethasone dipropionate + calcipotriol

This is a topical combination drug containing three active ingredients: - **Alitretinoin** is a retinoid (vitamin A derivative) that modulates cell differentiation and proliferation, primarily used for skin lesions associated with Kaposi's sarcoma. It acts by binding to retinoic acid receptors and retinoid X receptors, influencing gene expression involved in cell growth and immune response[6][8]. - **Betamethasone dipropionate** is a potent synthetic corticosteroid that reduces inflammation, itching, redness, and swelling by suppressing the local immune response through glucocorticoid receptor activation[3][5]. - **Calcipotriol** (calcipotriene) is a synthetic vitamin D3 analogue that regulates skin cell production and differentiation by binding to the vitamin D receptor. It helps normalize abnormal keratinocyte proliferation seen in psoriasis[2][5]. While fixed combinations of betamethasone dipropionate plus calcipotriol are widely approved for plaque psoriasis as topical ointments/foams/gels[1][2][3][4][5], there are no known marketed or clinically studied products combining all three agents—alitretinoin, betamethasone dipropionate, and calcipotriol—in one formulation. Each component has distinct mechanisms targeting hyperproliferation (alitretinoin/calcipotriol) or inflammation (betamethasone), suggesting potential utility in severe or refractory dermatologic conditions if combined.